[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Invited Critique
November 15, 2010

Risky Business: Identifying Risk Factors Associated With Lymphedema After Breast CancerComment on “Risk Factors for Lymphedema in a Prospective Breast Cancer Survivorship Study”

Author Affiliations

Author Affiliations: Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston (Drs Hunt and Cormier).

Arch Surg. 2010;145(11):1063-1064. doi:10.1001/archsurg.2010.1063

Most physicians agree that lymphedema is one of the most feared complications of breast cancer treatment. Most physicians will not agree, however, on the true incidence of lymphedema, how we should measure changes in the upper extremity, what constitutes clinically significant lymphedema, and when and how we should treat lymphedema. For a condition that is reported to be highly prevalent among breast cancer survivors (7%-70%), the risk factors for developing lymphedema are not well elucidated. In addition, it has been difficult to identify populations of at-risk survivors who may benefit from early intervention.

First Page Preview View Large
First page PDF preview
First page PDF preview
×